Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 601–700 of 1,002
Miller, J. D., Najafi, B., & Armstrong, D. G. (2015) · Current Geriatrics Reports · doi:10.1007/s13670-015-0136-7 · Cited by 36
“The American Diabetes Association (ADA) recommends adults maintain A1C levels <7 %; however, these guidelines are typically based on research from a younger, less comorbid cohort [47••, 48••]. These data typically do not take into account the unique set of complications present in frail or highly comorbid elderly indi…”
BackgroundGenetic basis of diabetic kidney disease and other diabetic complications
Sandholm, N., & Groop, P. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.01.002 · Cited by 35
Fructose-Induced Insulin Resistance as a Model of Neuropathic Pain in Rats
García, G., Gutierrez-Lara, E. J., Centurión, D., Granados‐Soto, V., & Murbartián, J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.063 · Cited by 37
Hansen, T. M., Muthulingam, J. A., Brock, B., Drewes, A. M., Juhl, A. H., Vorum, H., Jakobsen, P. E., Karmisholt, J., Brock, C., & Frøkjær, J. B. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.10.002 · Cited by 37
Xu, X., Chen, H., Ling, B., Xu, L., Cao, H., & Zhang, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1387-y · Cited by 34
“The PDPN symptoms are usually described by patients as prickling, like an electric shock, burning, or sharp, and these are often exacerbated at night([5]).”
BackgroundAdvances in diagnostics and outcome measures in peripheral neuropathies
Merkies, I. S. J., Faber, C. G., & Lauria, G. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.02.038 · Cited by 37
Self-citationImpaired peripheral nerve regeneration in type‐2 diabetic mouse model
Pham, V. M., Tu, N. H., Katano, T., Matsumura, S., Saito, A., Yamada, A., Furue, H., & Ito, S. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13771 · Cited by 33
HDAC6 as a potential therapeutic target for peripheral nerve disorders
Prior, R. C., Helleputte, L. V., Klingl, Y. E., & Bosch, L. V. D. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1541235 · Cited by 39
Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes
Lovshin, J. A., Lytvyn, Y., Lovblom, L. E., Katz, A., Boulet, G., Bjornstad, P., LAI, V. S., Cham, L., TSE, J. M., Orszag, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1809 · Cited by 35
Li, Q., Zhong, Y., Zhang, T., Zhang, R., Zhang, Q., Zheng, H., Ji, L., Sun, W., Zhu, X., Zhang, S., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.03.039 · Cited by 33
Vakilinia, S. R., Vaghasloo, M. A., Aliasl, F., Mohammadbeigi, A., Bitarafan, B., Etripoor, G., & Asghari, M. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102325 · Cited by 33
SHILLO, P. R., Yiangou, Y., DONATIEN, P. D., Greig, M., Selvarajah, D., Wilkinson, I. D., Anand, P., & Tesfaye, S. H. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.731658 · Cited by 33
Self-citationFan, J., Pan, Q., Gao, Q., Li, W., Xiao, F., & Guo, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2482453 · Cited by 37
“Diabetic peripheral neuropathy (DPN), which affects approximately 50% of patients with diabetes, is the most frequently encountered complication of long-term diabetes [1, 2].”
BackgroundStructural and functional assessment of skin nerve fibres in small‐fibre pathology
Karlsson, P., Nyengaard, J. R., Polydefkis, M. J., & Jensen, T. S. (2014) · European Journal of Pain · doi:10.1002/ejp.645 · Cited by 33
“A NeuroDiab expert panel proposed a diagnostic criteria for SFN irrespective of aetiology: (1) possible: presence of length-dependent symptoms and/or clinical signs of small-fibre damage; (2) probable: presence of length-dependent symptoms, clinical signs of small-fibre damage and normal sural nerve conduction study;…”
BackgroundHigh Energy Diets-Induced Metabolic and Prediabetic Painful Polyneuropathy in Rats
Xie, F., Han, F., Hou, J., Jiao, K., Costigan, M., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057427 · Cited by 37
“(2) Atypical DPN differs from the typical DPN in terms of onset, time course, manifestations, and the underlying mechanisms are unknown [13,17].”
BackgroundDuloxetine in Painful Diabetic Neuropathy
Hossain, S. M., Hussain, S. M., & Ekram, A. S. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000343 · Cited by 35
Distal Sensorimotor Neuropathy: Improvements in Diagnosis
Vas, P. R. J., Sharma, S., & Rayman, G. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.29 · Cited by 36
“Heart rate variability (HRV) employing interbeat (RR) intervals of the electrocardiogram is by far the most used technique with a reported specificity of 80% [9].”
BackgroundMethodInfluentialZhang, Y., Jiang, Y., Shen, X., & Yan, S. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2946-1 · Cited by 33
Cardiac autonomic function in children with type 1 diabetes
Metwalley, K. A., Hamed, S. A., & Farghaly, H. S. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3122-1 · Cited by 35
Acupuncture for the treatment of lower limb diabetic peripheral neuropathy: a systematic review
Nash, J., Armour, M., & Penkala, S. (2019) · Acupuncture in Medicine · doi:10.1136/acupmed-2018-011666 · Cited by 36
A new prospective on the role of melatonin in diabetes and its complications
Mok, J. X., Ooi, J. H., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2019) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0036 · Cited by 39
Gait Parameters and Peripheral Neuropathy in Patients With Diabetes: A Meta-Analysis
Wang, Z., Peng, S., Zhang, H., Sun, H., & Hu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891356 · Cited by 39
“The Toronto Consensus Panel on Diabetic Neuropathy defined DPN as a “symmetrical, length-dependent sensorimotor polyneuropathy attributable to metabolic and microvessel alterations as a result of chronic hyperglycemic exposure and cardiovascular risk covariates” (3).”
BackgroundKaabi, Y. A. (2022) · Molecules · doi:10.3390/molecules27217352 · Cited by 37
“T2DM and T2DM-linked cardiovascular complications, including macrophages/monocytes and atherosclerosis, have significant contributions in regulating inflammation.”
BackgroundInfluentialDioscin: Therapeutic potential for diabetes and complications
Gao, H., Wang, Z., Zhu, D., Zhao, L., & Xiao, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116051 · Cited by 36
Sayed, D., Deer, T. R., Hagedorn, J. M., Sayed, A., D'Souza, R. S., Lam, C. M., Khatri, N., Hussaini, Z., Pritzlaff, S. G., Abdullah, N. M., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s451006 · Cited by 40
Divišová, Š., Vlčková, E., Šrotová, I., Kincová, S., Škorňa, M., Dušek, L., Dubový, P., & Bednařík, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12890 · Cited by 34
Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings
Qureshi, M. S., Iqbal, M., Zahoor, S., Ali, J., & Javed, M. U. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0581-y · Cited by 39
Elsherbiny, N. M., Ahmed, E., Kader, G. A., Abdel–Mottaleb, Y., El-Sayed, M. H., Youssef, A. M., & Zaitone, S. A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.050 · Cited by 32
Galosi, E., Pietro, G. D., Cesa, S. L., Stefano, G. D., Leone, C. M., Fasolino, A., Lionardo, A. D., Leonetti, F., Buzzetti, R., Mollica, C., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.27080 · Cited by 40
“Diagnosis of pure small-fiber polyneuropathy relied on at least a symptom or symptoms (distally distributed thermal-pain sensory disturbances), or a sign or signs (distally distributed pinprick and thermal sensation abnormalities), normal NCS, and abnormal intraepidermal nerve fiber density (IENFD) at the calf.(9) The…”
BackgroundNarayan, S., Goel, A., Singh, A. K., Thacker, A. K., Singh, N. C., & Gutch, M. (2021) · British Journal of Radiology · doi:10.1259/bjr.20200173 · Cited by 32
The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy
Gylfadottir, S. S., Itani, M., Kristensen, A. G., Karlsson, P., Krøigård, T., Bennett, D., Tankişi, H., Andersen, N. T., Jensen, T. S., Sindrup, S. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263831 · Cited by 34
Is metformin a possible treatment for diabetic neuropathy?
Wei, J., Wei, Y., Huang, M., Wang, P., & Jia, S. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13310 · Cited by 34
Doty, M. E., Yun, S., Wang, Y., Hu, M., Cassidy, M. M., Hall, B., & Kulkarni, A. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-21394-y · Cited by 34
Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers–Danlos syndromes
Igharo, D., Thiel, J. C., Rolke, R., Akkaya, M., Weis, J., Katona, I., Schulz, J. B., & Maier, A. (2022) · European Journal of Neurology · doi:10.1111/ene.15649 · Cited by 35
“, burning sensations, numbness, paraesthesia) or clinical signs (hypesthesia, hyperalgesia or allodynia) and an abnormal thermal quantitative sensory testing (QST) and/or a reduced IENFD at the distal leg [21].”
BackgroundMethodInfluentialVági, O. E., Svébis, M. M., Domján, B. A., Körei, A. E., Tesfaye, S. H., Horváth, V. J., Kempler, P., & Tabák, Á. G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1079009 · Cited by 34
Self-citationDiabetic peripheral neuropathy, is it an autoimmune disease?
Janahi, N. M., Santos, D., Blyth, C., Bakhiet, M., & Ellis, M. J. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.09.009 · Cited by 32
Corneal sensitivity is related to established measures of diabetic peripheral neuropathy
Pritchard, N., Edwards, K. P., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2012) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2012.00729.x · Cited by 34
Self-citationNon-linear contribution of serum vitamin D to symptomatic diabetic neuropathy: A case-control study
Esteghamati, A., Fotouhi, A., Faghihi‐Kashani, S., Hafezi‐Nejad, N., Heidari, B., Sheikhbahaei, S., Zandieh, A., & Nakhjavani, M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.018 · Cited by 32
Vas, P. R. J., Green, A. Q., & Rayman, G. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2417-9 · Cited by 31
“It is also known that duration of diabetes and cardiovascular risk factors are associated with the development of clinical large fibre neuropathy [17, 22].”
BackgroundBrain changes in diabetes mellitus patients with gastrointestinal symptoms
Drewes, A. M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i2.14 · Cited by 32
Bordier, L., Dolz, M., Monteiro, L., Névoret, M.-L., Calvet, J., & Bauduceau, B. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00018 · Cited by 34
“Small fibers can be sensory or autonomic and there are several methods to assess small fiber function or structure (7).”
MethodAl‐Maskari, F. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000346 · Cited by 32
“, Toronto criteria, San Antonio Consensus and Mayo Clinic criteria) [4,20,21].”
BackgroundSudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes
Ang, L. P., Jaiswal, M., Callaghan, B. C., Raffel, D. M., Brown, M. B., & Pop‐Busui, R. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.03.001 · Cited by 32
“Discussion In this pilot study we evaluated the associations between several established and sensitive measures of CAN, and ESC assessed by SUDOSCAN, as an indirect measure of sudomotor function in patients with T1D with an early course of disease.”
BackgroundMethodInfluentialHiyama, H., Yano, Y., So, K., Imai, S., Nagayasu, K., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2018) · Molecular Pain · doi:10.1177/1744806918789812 · Cited by 33
“Diabetic peripheral neuropathy (DPN) is a common long-term complication of diabetes that affects up to 50% of patients with diabetes.(1) Bilateral and symmetrical damage to peripheral nerves progresses with a distal”
BackgroundMonastiriotis, C., Παπάνας, Ν., Trypsianis, G. A., Karanikola, K., Veletza, S. V., & Maltezos, E. S. (2012) · Angiology · doi:10.1177/0003319712453645 · Cited by 33
“Furthermore, patients in group B had longer T2DM duration (12 [1-36] vs 10 [0-38] years, P 1⁄4 .”
BackgroundZhou, P., Zhou, J., Li, J., Qin, L., Hu, W. F., Zhang, X., Wang, J. X., & Shi, Z. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1564867 · Cited by 37
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy
Petrova, N. L., & Shanahan, C. M. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2511-6 · Cited by 31
“Neuropathy is a common complication of diabetes and is an important risk factor for diabetic foot complications [40].”
BackgroundBariatric Surgery and Microvascular Complications of Type 2 Diabetes Mellitus
Jackson, S., le Roux, C. W., & Docherty, N. G. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0453-x · Cited by 33
Kou, Z., Li, C., Hu, J.-C. E., Yin, J.-B., Zhang, D., Liao, Y., Wu, Z.-Y., Ding, T., Qu, J., Li, H., et al. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00006 · Cited by 33
“It has been confirmed that DPN is irreversible when nerves are destroyed, so early intervention is very important to prevent neuropathic complications in patients with diabetes (Boulton et al., 2005; Tesfaye et al., 2010).”
Dehghani, C., Srinivasan, S., Edwards, K. P., Pritchard, N., Russell, A. W., Malik, R. A., & Efron, N. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21801 · Cited by 31
Self-citationYoshioka, K. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0339-3 · Cited by 35
“Diabetic peripheral neuropathy (DPN) was diagnosed if two or more of the following were present: neuropathic symptoms (decreased sensation, positive neuropathic sensory symptoms), symmetric decreased distal sensation, and unequivocally decreased or absent ankle reflexes.”
BackgroundInfluentialHansen, C. S., Færch, K., Jørgensen, M. E., Malík, M., Witte, D. R., Brunner, E. J., Tabák, Á. G., Mika Kivimaki, B., & Vistisen, D. (2019) · Diabetes Care · doi:10.2337/dc18-1838 · Cited by 36
“In addition to established cardiometabolic risk factors, CAN is an independent determinant of cardiovascular morbidity, progression of diabetic nephropathy and overall mortality(4-6).”
BackgroundMäättä, L. L., Charles, M., Witte, D. R., Bjerg, L., Jørgensen, M. E., Jensen, T. S., & Andersen, S. T. (2019) · Diabetes Care · doi:10.2337/dc19-0869 · Cited by 31
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 33
Pal, K., Horsfall, L., Sharma, M., Nazareth, I., & Petersen, I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001989 · Cited by 37
Kec, D., Rajdová, A., Raputová, J., Adamová, B., Šrotová, I., Nekvapilová, E. K., Michalčáková, R. N., Horáková, M., Bělobrádková, J., Olšovský, J., et al. (2021) · European Journal of Pain · doi:10.1002/ejp.1865 · Cited by 36
Involvement of Cutaneous Sensory Corpuscles in Non-Painful and Painful Diabetic Neuropathy
García‐Mesa, Y., Feito, J., Gay, M. G., Martínez, I. G., García‐Piqueras, J., Martín‐Cruces, J., Viña, E., Cobo, T., & García‐Suárez, O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194609 · Cited by 34
“In any case, the evidence suggests that an increasing severity of DDSP may increase the risk of developing painful neuropathic symptoms thus frequently evolving to P DDSP [2,37].”
BackgroundStrand, N. H., Wie, C. S., Peck, J., Maita, M., Singh, N., Dumbroff, J., Francio, V. T., Murphy, M. T., Chang, K., Dickerson, D. M., et al. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01044-8 · Cited by 36
Sachan, N., Saraswat, N., Chandra, P., Khalid, M., & Kabra, A. (2022) · BioMed Research International · doi:10.1155/2022/8263999 · Cited by 31
Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus
Moțățăianu, A., Bălașa, R., Voidăzan, S. T., & Bajkó, Z. (2013) · BioMed Research International · doi:10.1155/2013/507216 · Cited by 31
“The American Diabetes Association (ADA) considers cardiovascular reflex tests to be the appropriate diagnostic tests for CAN because they have good sensitivity, specificity, and reproducibility, and they are easily performed [4].”
BackgroundInfluentialDiabetic neuropathy and heart failure: role of neuropeptides
Ejaz, A., LoGerfo, F. W., & Pradhan, L. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001979 · Cited by 31
Diabetic peripheral neuropathy: resource utilization and burden of illness
Mehra, M., Merchant, S., Gupta, S., & Potluri, R. C. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.928639 · Cited by 32
Saad, M., Psimaras, D., Tafani, C., Sallansonnet-Froment, M., Calvet, J., Vilier, A., Tigaud, J., Bompaire, F., Lebouteux, M., de Greslan, T., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2049-x · Cited by 31
Pereira, V. L., Dobre, M. A., dos Santos, S. G., Fuzatti, J. S., Oliveira, C. R., Campos, L. A., Brateanu, A., & Baltatu, O. C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00248 · Cited by 31
“Deep breathing test appears to have the greatest specificity (∼80%) (Tesfaye et al., 2010).”
BackgroundBalaha, M. F. H., Kandeel, S., & Kabel, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.135 · Cited by 32
Neuropathic pain in diabetes mellitus: Challenges and future trends
Singh, R., Rao, H. K., & Singh, T. G. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100215 · Cited by 33
Prevalence and determinants of diabetic polyneuropathy in a sub-Saharan African referral hospital
Kuate-Tegueu, C., Temfack, E., Ngankou, S., Doumbe, J. N., Djientcheu, V., & Kengne, A. P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.035 · Cited by 32
Wu, L.-Y., Li, M., Qu, M., Li, X., Pi, L., Chen, Z., Zhou, S., Yi, X., Shi, X., Wu, J., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.11.025 · Cited by 31
Kamiya, H., Shibata, Y., Himeno, T., Tani, H., Nakayama, T., Murotani, K., Hirai, N., Kawai, M., Asada‐Yamada, Y., Asano‐Hayami, E., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13386 · Cited by 32
Mathiyalagen, P., Kanagasabapathy, S., Kadar, Z., Rajagopal, A., & Vasudevan, K. (2021) · Cureus · doi:10.7759/cureus.15493 · Cited by 38
Bönhof, G. J., Sipola, G., Strom, A., Herder, C., Straßburger, K., Knebel, B., Reule, C., Wollmann, J.-C., Icks, A., Al‐Hasani, H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057142 · Cited by 32
Jiang, X., Deng, F., Rui, S., Ma, Y., Wang, M., Deng, B., Wang, H., Du, C., Chen, B., Yang, X., et al. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s361698 · Cited by 32
Deng, W., Dong, X., Zhang, Y., Jiang, Y., Lu, D., Wu, Q., Liang, Z., Yang, G., & Chen, B. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.012 · Cited by 32
Ha, B. K., Kim, B. G., Kim, D. H., Lee, S. I., Jung, S. M., Park, J. Y., Lee, C. W., Kim, S. S., Kim, B. H., & Kim, I. J. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.6.443 · Cited by 31
Kim, S. K., Lee, K. J., Hahm, J. R., Lee, S. M., Jung, T. S., Jung, J. H., Kim, S., Kim, D. R., Ahn, S.-K., Choi, W., et al. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.1.64 · Cited by 31
Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes
Rajaobelina, K., Farges, B., Nov, S., Maury, E., Cephise-Velayoudom, F. L., Gin, H., Helmer, C., & Rigalleau, V. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2832 · Cited by 34
“been shown to develop early in patients with DPN even when large myelinated fibre function is still normal [35].”
BackgroundMethodLeone, C. M., Celletti, C., Gaudiano, G., Puglisi, P. A., Fasolino, A., Cruccu, G., Camerota, F., & Truini, A. (2020) · Pain Medicine · doi:10.1093/pm/pnaa038 · Cited by 37
Heart rate variability is severely impaired among type 2 diabetic patients with hypertension
Istenes, I., Körei, A. E., Putz, Z., Németh, N., Martos, T., Keresztes, K., Kempler, M., Vági, O. E., Vargha, P., & Kempler, P. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2496 · Cited by 34
Self-citationPatel, N., Mishra, V., Patel, P., & Dikshit, R. K. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-62 · Cited by 29
Silva, M., Costa‐Pereira, J. T., Martins, D., & Tavares, I. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.002 · Cited by 31
Diabetes Mellitus and Diabetic Peripheral Neuropathy
Bruschi, L. K. M., da Rocha, D. A., Filho, E. L. G., Barboza, N. D. M. P., Frisanco, P. A. B., Callegaro, R. M., de Sá, L. B. P. C., & Arbex, A. K. (2017) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2017.71002 · Cited by 36
“Factors such as DM long duration, ischemia of the peripheral nerves, glycemic variability, and poor glycemic control, are related to a higher risk of DN [4] [6] [7] [10] [11] [12].”
Won, J. C., Im, Y., Lee, J., Kim, C. H., Kwon, H., Cha, B., & Park, T. S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5751687 · Cited by 29
“Recently, it is suggested that DPN could be diagnosed by its typical symptom(s) and/or sign(s) in clinical terms [2].”
BackgroundMethodInfluentialPrevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
Barbosa, M., Saavedra, A., Oliveira, S. C., Reis, L. D. D., Rodrigues, F., Severo, M., Sittl, R., Maier, C., & Carvalho, D. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00402 · Cited by 32
“The risk factors for the development of DSPN in patients with DM1 are age, duration of diabetes, poor glycemic control (5, 10), height (11) (may be because nerve length is bigger in taller persons), smoking (12), hypertension, and lipid profile (13, 14).”
BackgroundKhan, K. S., Christensen, D. H., Nicolaisen, S. K., Gylfadottir, S. S., Jensen, T. S., Nielsen, J. S., Thomsen, R. W., & Andersen, H. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13542 · Cited by 31
Small fiber neuropathy: Swiss cohort characterization
Bitzi, L. M., Lehnick, D., & Wilder-Smith, E. P. (2021) · Muscle & Nerve · doi:10.1002/mus.27340 · Cited by 29
“Diagnostic criteria have recently been established, and diagnostic categories of clinically possible, probable, and definite have been proposed.(2) To date, epidemiology and demographics have been examined by only one retrospective study, which found a minimum incidence of SFN of 11.”
Mercan, A., Uzun, S. T., Keleş, S., Hacıbeyoğlu, G., Yılmaz, R., & Reıslı, R. (2021) · The Korean journal of pain · doi:10.3344/kjp.2021.34.4.463 · Cited by 33
“The diabetic neuropathy diagnosis was based on clinical symptoms or signs and expert panels at the International Symposium on Diabetic Neuropathy in Toronto, 2009 [32].”
MethodStem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
Akter, S., Choubey, M., Mohib, M. M., Arbee, S., Sagor, M. A. T., & Mohiuddin, M. S. (2023) · Brain Sciences · doi:10.3390/brainsci13020255 · Cited by 29
Reynolds, E. L., Watanabe, M., Banerjee, M., Chant, E., Villegas‐Umana, E., Elafros, M. A., Gardner, T. W., Pop‐Busui, R., Pennathur, S., Feldman, E. L., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05899-3 · Cited by 31
“We defined clinical PN using the Toronto Consensus Definition of probable neuropathy as determined by one of six neuromuscular specialists (including BCC); this required the presence of at least two neuropathy symptoms, abnormal sensory examination or abnormal reflexes [22].”
MethodState of the art paper APOE gene polymorphisms and diabetic peripheral neuropathy
Monastiriotis, C., Παπάνας, Ν., Veletza, S. V., & Maltezos, E. S. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.30279 · Cited by 29
“Future studies should employ more robust and reproducible methodology [42-45], but also adjust for potential confounders, as well as for the prevalence of neuropathy in the general diabetic population.”
MethodDyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy
Al-Nimer, M. S. M., Al-Ani, F. S., & Ali, F. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.81940 · Cited by 31
“[1] It results from microvascular injury involving small blood vessels that supply nerves , but macrovascular pathogenesis is also involved.[2] The pathogenesis of sensorimotor neuropathy in diabetes mellitus type 2 is multifactorial and related metabolic disturbances, such as hyperglycemia, dyslipidemia, oxidative an…”
BackgroundJung, C., Baek, A.-R., Kim, K.-J., Kim, B., Kim, C., Kang, S., & Mok, J. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.4.309 · Cited by 30
Contact Heat-Evoked Potential Stimulation for the Evaluation of Small Nerve Fiber Function
Parson, H. K., Nguyen, V. T., Orciga, M., Boyd, A. L., CASELLINI, C. M., & Vinik, A. I. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0202 · Cited by 29
Self-citationOptimizing temperature threshold testing in small-fiber neuropathy
Bakkers, M., Faber, C. G., Reulen, J. P. H., Hoeijmakers, J. G. J., Vanhoutte, E. K., & Merkies, I. S. J. (2014) · Muscle & Nerve · doi:10.1002/mus.24473 · Cited by 29
“4% retained their previous classification when using the newly established protocol, and 86% had no classification change when applying the recently published SFN definition.(1) These findings appear to be acceptable with regard to reduced patient burden, especially as there is no gold standard for the diagnosis of SF…”
MethodKasznicki, J., Śliwińska, A., Kosmalski, M., Merecz-Sadowska, A., Majsterek, I., & Drzewoski, J. (2015) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.10.006 · Cited by 29
Structural and functional characterization of nerve fibres in polyneuropathy and healthy subjects
Karlsson, P., Haroutounian, S., Polydefkis, M. J., Nyengaard, J. R., & Jensen, T. S. (2015) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2015.08.007 · Cited by 29
Suda, E. Y., Madeleine, P., Hirata, R. P., Samani, A., KAWAMURA, T., & Sacco, I. D. C. N. (2017) · Clinical Biomechanics · doi:10.1016/j.clinbiomech.2017.01.001 · Cited by 29
“DPN affects approximately 50% of all the diabetic population (Tesfaye et al., 2010).”
BackgroundComplications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Plutzky, J., & Boulton, A. J. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00033-2 · Cited by 43
Self-citationRolim, L. C., da Silva, E. M. K., de Sá, J. R., & Dib, S. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00285 · Cited by 32
Wang, X., Lin, H., Xu, S., Yuanlin, J., & Zhang, R. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s168878 · Cited by 29
“Introduction Diabetic neuropathy (DN) is a very common, symptomatic, long-term complication of diabetes mellitus, affecting nearly 50% of patients with type 1 and/or type 2 diabetes.(1) According to International Diabetes Federation data, ~592 million people worldwide will be diagnosed with diabetes by 2035.”
Evaluating the Phase II drugs currently under investigation for diabetic neuropathy
Adeghate, E. A., Fehér, E., & Kalász, H. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954033 · Cited by 29
“In one study, it was observed that at least 20% of diabetic patients have abnormal autonomic innervation of the heart [22].”
Background
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.